Financial Performance - The company's revenue for Q3 2022 reached ¥365,095,595.66, representing a 187.37% increase year-over-year[5]. - Net profit attributable to shareholders was ¥40,052,611.27, up 104.77% compared to the same period last year[5]. - Operating income for the year-to-date reached ¥801,715,694.16, an 80.69% increase compared to the same period last year[9]. - Total operating revenue for the current period reached ¥801,715,694.16, a significant increase from ¥443,689,774.48 in the previous period, representing an increase of approximately 80.7%[19]. - Net profit for the current period was ¥75,673,586.96, compared to ¥69,386,112.41 in the previous period, indicating an increase of approximately 9.3%[20]. - Basic earnings per share for the period was ¥0.0834, a 53.56% increase year-over-year[5]. - Basic and diluted earnings per share were both reported at ¥0.1577, down from ¥0.1927 in the previous period[20]. Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥2,159,715,602.97, reflecting a 175.44% increase from the previous year-end[5]. - Current assets amounted to CNY 1,877,991,507.93, up from CNY 524,332,157.59 at the start of the year, indicating a growth of about 258%[16]. - Total liabilities rose to CNY 552,377,982.14 from CNY 130,021,302.75, marking an increase of approximately 325%[17]. - The company's equity attributable to shareholders increased to CNY 1,607,337,620.83 from CNY 654,069,040.90, reflecting a growth of about 145%[17]. Cash Flow - Cash flow from operating activities generated a net amount of ¥131,748,918.63, a turnaround from a negative cash flow of ¥26,085,255.11 in the previous period[21]. - Cash inflow from investment activities totaled ¥2,035,236,249.61, significantly higher than ¥310,059,894.49 in the previous period[21]. - The company reported a net cash outflow from investment activities of ¥1,144,489,457.56, compared to a smaller outflow of ¥50,531,199.38 in the previous period[21]. - Cash flow from financing activities resulted in a net inflow of ¥1,017,183,756.24, contrasting with a net outflow of ¥10,015,000.00 in the previous period[22]. - The company’s cash and cash equivalents at the end of the period stood at ¥294,680,394.39, up from ¥19,321,302.64 at the end of the previous period[22]. Investments and Receivables - The company reported a significant increase in accounts receivable, which rose by 133.69% to ¥68,132,376.80 due to increased business volume[9]. - The company experienced a 341.81% increase in financing receivables, totaling ¥49,109,713.08, attributed to higher business activity[9]. - The company reported a 471.47% increase in investment income, amounting to ¥12,196,249.61, due to higher returns from structured deposits[9]. Borrowings and Financial Strategy - The company has seen a significant rise in short-term borrowings, which increased by 1,854.58% to ¥150,009,333.33, indicating a strategy to leverage for growth[9]. - Short-term borrowings surged to CNY 150,009,333.33, compared to CNY 7,674,748.24 at the beginning of the year, representing an increase of over 1,900%[17]. Other Financial Metrics - The total number of restricted shares at the end of the period was 360,000,000, with 7,322,657 shares released during the current period[13]. - The company plans to unlock 343,800,000 shares of restricted stock by March 22, 2025, as part of its initial public offering restrictions[13]. - The company has increased its prepayments to CNY 105,221,606.33 from CNY 21,958,564.31, showing a growth of approximately 378%[16]. - Inventory levels were reported at CNY 94,330,547.13, up from CNY 89,225,313.34, indicating a growth of approximately 6%[16]. - The company experienced a decrease in financial expenses, reporting a net financial income of ¥6,689,926.08 compared to an expense of ¥285,227.00 in the previous period[19].
华融化学(301256) - 2022 Q3 - 季度财报